MedPath

Clinical verification of an improved assay of "NX-PVKA-R", which associated with des-gamma-carboxyprothrombin, for diagnosis of patients with hepatocellular carcinoma

Not Applicable
Conditions
Hepatocellular carcinoma
Registration Number
JPRN-UMIN000007196
Lead Sponsor
Department of Gastroenterology and Metabology, Ehime University Graduate School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
25
Inclusion Criteria

Not provided

Exclusion Criteria

1. The patients who have poorly controlled cardiovascular, hematologic or pulmonary disease 2. The patients with pregnancy 3. The patients with severe depression or other psychiatric disorders

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Sensitivity and specificity of PIVKA-II, NX-PVKA, NX-PVKA-R and AFP to diagnose HCC
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath